Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Alkermes Plc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $100 Billion
- Q4 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Alkermes Plc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 884 shares of ALKS stock, worth $29,614. This represents 0.0% of its overall portfolio holdings.
Number of Shares
884
Previous 884
-0.0%
Holding current value
$29,614
Previous $24,000
4.17%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ALKS
# of Institutions
365Shares Held
176MCall Options Held
166KPut Options Held
118K-
Black Rock Inc. New York, NY29.1MShares$975 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$620 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$435 Million0.04% of portfolio
-
State Street Corp Boston, MA9.19MShares$308 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.01MShares$235 Million0.04% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.5B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...